Archive

One-year follow-up outcomes of treatment of wet age-related macular degeneration with aflibercept Journal > /en/journal/2018/2/1
Purpose: To evaluate one-year follow-up outcomes of the treatment with aflibercept in patients with newly diagnosed wet age-related macular degeneration (AMD). Methods: It was a retrospective analysis of 28 eyes of 28 patients with an average age of 74,2 years, who were treated with aflibercept at the Department of Ophthalmology,University Hospital Královské Vinohrady in Prague. All patients were ...
Result of the first 12 months of treatment of macular edema complicating brvo in patients treated with ranibizumab Journal > /en/journal/2018/2/3
The aim of the study: Retrospective evaluation of the first 12 months treatment of macular edema in BRVO with ranibizumab based on anatomical and functional parameters. Methods: 54 eyes with macular edema complicating BRVO were included in the study, with an average initial best corrected visual acuity 4/16 ETDRS charts, an average central retinal thickness 512.3 μm, and in average 4 months till t...